Unite for ALS

Unite for ALS has been a member of Linktree for 4 years and joined in November 2021. The social media accounts linked to from Unite for ALS are: • Facebook • YouTube • LinkedIn • Email • X Besides social media accounts, unitegenomics has populated their site with: • Who We Are • Unite's Clinical Trial Concierge Program • Unite Platform Sign Up • Let's Overcome This Disease Together • Research Webinar: Targeting the Brain for ALS Therapies • New Study Investigating Long-term Safety, Effectiveness of Reldesemtiv • SBT-272, in Phase 1 Trial, Continues to Protect Motor Neurons in Mice • New research on the experimental drug, NU-9 • Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the U.S. Food and Drug Administration (FDA) has approved RADICAVA ORS® • #ACTforALS Funding Opportunity Annoucement • Locanabio's Proprietary CORRECTx™ RNA-Targeting Gene Therapy Reduces Disease-Causing Hexanucleotide Repeat Expansions • ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS) • Mutations in 22 Genes Linked to Sporadic ALS in Large Group Study • Scott's Story • Potential window for treating ALS Identified • Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035 • ProJenX launches to advance novel, targeted therapies for ALS • Brainstorm Cell Therapeutics Inc NurOwn has taken the ALS community by storm with new genetic data • Motor neuron toxin associated with ALS identified • EverythingALS joins together with MTHA to research new digital biomarkers for #ALS. • Tau Protein Levels May Be Useful Biomarkers of ALS Progression • Amarna Therapeutics and Redoxis receive EUREKA Eurostars grant to establish a screening platform for the advancement of a potential first-in-class gene therapy for ALS • NurOwn Dosing Likely to Continue for ALS Patients in Its EAP • Clinical Trial Research on Brian-Computer Interfaces • YOUR ALS GUIDE: For ALS Caregivers • ALS PATHWAYS: ALS CAREGIVERS SUPPORT • I AM ALS: CAREGIVING TOOLKIT